Latest News
Conference Coverage
Heart-healthy actions promote longer, disease-free life
Stronger measures of cardiovascular health were linked to longer life expectancy and fewer chronic conditions.
From the Journals
Keto/paleo diets ‘lower quality than others,’ and bad for planet
Both keto and paleo diets tend to be higher in animal foods and lower in plant foods than other popular diets.
Latest News
Do artificial sweeteners alter postmeal glucose, hunger hormones?
Drinking a sugar-sweetened beverage had a different effect on postprandial levels of glucose than drinking a no-or low-calorie nonnutritive...
Conference Coverage
High CV risk factor burden in young adults a ‘smoldering’ crisis
Cardiovascular risk factors are “unacceptably” high and are increasing among young adults, prompting calls for aggressive preventive measures.
Conference Coverage
Long-term BP reductions with renal denervation not race specific
Long-term blood pressure reductions in the Black patient cohort of the SYMPLICITY renal denervation trial challenge early results.
Conference Coverage
COORDINATEd effort boosts optimal therapy in patients with T2D and ASCVD
From the Journals
What happens if we sit for more than 8 hours per day?
“We used to believe that any intense physical exercise could compensate for a sedentary life,” says expert.
Conference Coverage
Causal AI quantifies CV risk, providing patient-specific goals
Causal artificial intelligence is showing how specific risk factors can be overcome to avoid cardiovascular events.
From the Journals
Biomarkers linked to elevated T2D MACE risk in DECLARE-TIMI 58
A secondary DECLARE-TIMI 58 trial analysis linked two biomarkers to higher cardiovascular risks in diabetes and found a strong benefit of...
Conference Coverage
NUDGE-FLU: Electronic ‘nudges’ boost flu shot uptake in seniors
Two strategies based on electronically delivered letters or “nudges” were found to increase flu shot uptake, compared with usual care, a new study...
Conference Coverage
Bempedoic acid cuts CV events in statin-intolerant patients: CLEAR Outcomes
The CLEAR Outcomes trial establishes this new drug as an important addition to available nonstatin LDL cholesterol–lowering therapies, experts say...